Chimeron Bio
Philadelphia
About Chimeron Bio
Chimeron Bio develops an agent for personalized cancer gene therapy. The company focuses on discovering and developing personalized immunotherapeutics that will revolutionize the treatment of cancer. The company was founded in 2015 and is headquartered in Philadelphia, Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $14.0M
- Last round: Series Unknown (Mar 2025)
- Website: chimeronbio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/chimeron-bio-34657 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.